A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
Sebastián Riquelme is one of the pioneers in the growing field of immunometabolism, investigating how the processes that turn food into energy impact the outcome of infectious diseases.
The coming COVID boosters aren't the only vaccines adults should consider. Now's a good time for people over 18 to make sure they're up to date with flu, tetanus, and other routine vaccines.
Twenty years ago, when AIDS was devastating communities in sub-Saharan Africa, Columbia's Wafaa El-Sadr created an organization to save lives in some of the continent’s hardest-hit countries.
A study involving Columbia researchers finds that malaria parasites in Africa have developed resistance to artemisinin drugs, which could worsen malaria’s impact if partner drugs fail in the future.